| Literature DB >> 29861733 |
Hailu Getachew1, Awoke Derbie2, Daniel Mekonnen2.
Abstract
BACKGROUND: The hospital environment is a source of medically important pathogens that are mostly multidrug resistant (MDR) and posing a major therapeutic challenge. The aim of this study was to assess the surface and air bacteriology of selected wards at Felege Hiwot Referral Hospital (FHRH), Northwest Ethiopia.Entities:
Year: 2018 PMID: 29861733 PMCID: PMC5971317 DOI: 10.1155/2018/6413179
Source DB: PubMed Journal: Int J Microbiol
Figure 1Types and frequency of bacterial isolates identified from the surface and of FHRH, 2017.
Mean bacterial counts from air sample at FHRH, 2017 [20, 26].
| Site | Mean bacterial load Cfu/dm2/hr | Standard (cfu/dm2/hr)∗ | ||
|---|---|---|---|---|
| Optimal | Acceptable | Unacceptable | ||
| Surgical ward | 721 cfu/dm2 | 0–250 | 251–450 | >450 |
| OR (active) | 294.4 cfu/dm2 | 0–60 | 61–90 | >90 |
| Maternity | 619.3 cfu/dm2 | NS | 251–451 | >451 |
| NICU | 292.8 cfu/dm2 | NS | 51–90 | >90 |
| ICU | 246.9 cfu/dm2 | 0–250 | 251–450 | >450 |
| Orthopedics | 580.2 cfu/dm2 | NS | NS | NS |
| Dialysis | 135.8 cfu/dm2 | NS | NS | NS |
∗Debatable whether the listed standards are commonly accepted; NS, no standard set.
Distribution of antimicrobial resistance profile of bacterial pathogens isolated from surfaces and air at FHRH, 2017.
| Antibiotics | Bacteria isolates and their antibiotic resistance pattern | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Cotrimoxazole | 35 (49.5%) | 48 (57.7%) | 8 (36.4%) | 7 (100%) | 6 (100%) |
| Chloramphenicol | 20 (28%) | 26 (31%) | 7 (32%) | 4 (57.2%) | 4 (66.7%) |
| Gentamicin | 19 (26.7%) | 26 (30.5%) | 9 (41%) | 2 (28.6%) | 4 (66.7%) |
| Tetracycline | 29 (41%) | 45 (53.4%) | 7 (32%) | 5 (71.6%) | 4 (66.7%) |
| Cefoxtin | 18 (25%) | 24 (29%) | NA | NA | NA |
| Clindamycin | 12 (16.3%) | 14 (17.2%) | NA | NA | NA |
| Doxycyclin | 17 (24.5%) | 24 (29%) | NA | NA | NA |
| Erythromycin | 54 (75.5%) | 59 (70.2%) | NA | NA | NA |
| Clarithromycin | 50 (70%) | 66 (78.5%) | NA | NA | NA |
| Ciprofloxacin | 16 (22.5%) | 20 (24%) | 5 (23%) | 6 (85.7%) | 4 (66.7%) |
| Norfloxacillin | 17 (24%) | 19 (22.6%) | 4 (18.2%) | 0 (0%) | 2 (33.3%) |
| Augmentin | 16 (22.5%) | 16 (19%) | 5 (23%) | IR | 3 (50%) |
| Penicillin | 60 (84.5%) | 74 (88%) | NA | NA | NA |
| Ceftriaxone | 23 (32.4%) | 54 (64%) | 9 (41%) | IR | 1 (12.7%) |
| Ampicillin | NA | NA | 12 (54.6%) | IR | 6 (100%) |
NA, not applicable; Augmentin, amoxicillin/clavulanic acid; IR, intrinsic resistance.
Multidrug-resistant (MDR) profile of the isolates from surface and air of FHRH, 2017.
| Types of spp. | Antibiogram profile | |||||
|---|---|---|---|---|---|---|
| R0 | R1 | R2 | R3 | R4 | ≥ R5 | |
| Gram positive |
|
|
|
|
|
|
|
| 8 (11.3%) | 8 (11.3) | 14 (19.7%) | 11 (15.5%) | 6 (8%) | 24 (33.8%) |
|
| 1 (1.2%) | 10 (11.9%) | 1 (1.2%) | 16 (19%) | 8 (9.5%) | 48 (57.1%) |
| Gram negative |
|
|
|
|
|
|
|
| 4 (18.2%) | 9 (40.9%) | 1 (4.5%) | 1 (4.5%) | 0 | 7 (31.8%) |
|
| 0 | 0 | 2 (33.3%) | 0 | 0 | 4 (66.7%) |
|
| 0 | 0 | 0 | 1 (14.3%) | 1 (14.3%) | 5 (71.4%) |
| Total | 13 (9.8%) | 28 (14.7%) | 18 (9.5%) | 29 (15.3%) | 30 (15.8%) | 88 (46.3%) |
R0 = sensitive to all drugs, R1 = resistance to one drug, R2 = resistance to two drugs, R3 = resistance to three drugs, R4 = resistance to four drugs, and R5 = resistance to five drugs.